Interleukin-23 inhibition for the treatment of psoriasis: the next frontier for high-efficacy biologic therapy.
Department of Dermatology, University of Connecticut Health Center, 21 South Road, 2nd Floor, Farmington, CT, 06032, U.S.A. strober@uchc.edu.
B
B
Strober
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001691:Biological Therapy; D006801:Humans; D053759:Interleukin-23; D011565:Psoriasis / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D053759:Interleukin-23